Results 151 to 160 of about 9,997,733 (366)
Advanced Materials, EarlyView.Detecting proteins secreted by a single cell while retaining its viability remains challenging. A particles‐in‐particle (PiPs) system made by co‐encapsulating barcoded microparticles (BMPs) with a single cell inside an alginate hydrogel particle is introduced.
Félix Lussier +10 more
wiley +1 more source
MIDDLESEX HOSPITAL. TWO CASES OF ORBITAL TUMOUR, TREATED BY FIRST EXTIRPATING THE DISEASE, AND THEN APPLYING THE CHLORIDE-OF-ZINC PASTE [PDF]
G.J. Lawson
openalex +1 more source
Endoscopic orbital decompression for thyroid eye disease [PDF]
, 1998 Riaz Asaria +3 more
openalex +1 more source
Peptide Amphiphiles Hitchhike on Endogenous Biomolecules for Enhanced Cancer Imaging and Therapy
Advanced Materials, EarlyView.Weakly assembled peptide amphiphile nanostructures disassemble in circulation and reassemble with blood biomolecules, mainly lipoproteins. Binding to blood biomolecules prolongs blood circulation and improves accumulation in solid tumors. In the tumor microenvironment, peptide amphiphiles assemble with cholesterol‐rich domains of cell membranes ...
Li Xiang +19 more
wiley +1 more source
Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease
European Thyroid JournalBackground: Thyroid eye disease (TED) is an autoimmune orbital disease, with intravenous glucocorticoid (IVGC) therapy as the first-line treatment.
Haiyang Zhang +6 more
doaj +1 more source
Advanced Materials, EarlyView.This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding +11 more
wiley +1 more source
SONOLOGY IN ORBITAL HYDATID DISEASE [PDF]
, 1999 KK Sen, Mandeep Saini, Amarjit Singh
openalex +1 more source
Advanced Materials, EarlyView.This study introduces glutathione‐stabilized gold nanoparticles for targeted lithium delivery (LiG‐AuNPs), enabling the controlled modulation of Glycogen Synthase Kinase‐3 (GSK‐3β). These non‐toxic, 2‐nm particles release lithium intracellularly, effectively inhibiting GSK‐3β in the brain without significant plasma lithium alterations.
Antonio Buonerba +20 more
wiley +1 more source
Advanced Materials Interfaces, EarlyView.The Au‐LNA Raman probe, composed of gold nanoparticles (AuNPs), thiol functional group, and Cy3 modified LNAs, synthesized after hybridization of LNA and miR‐210‐3p target, is integrated into the MoS2@Au composite. The integration of the nanocomposite is formed by physical adsorption of Au‐LNA nanohybrid with MoS2. Characterization confirms morphology,
Faith Mokobi Zablon +4 more
wiley +1 more source